Skip to main content
Log in

Limb girdle weakness responding to salbutamol: An Indian family with DOK7 mutation

  • Case Reports
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Background

Congenital Myasthenic Syndromes (CMS) are heterogeneous genetic diseases.

Case characteristics

Two siblings presented with progressive limb girdle weakness without significant fluctuations or ocular muscle weakness. Repetitive nerve stimulation showed a decremental response and there was no response to pyridostigmine therapy.

Outcome

A trial of salbutamol produced a remarkable, consistent improvement. Mutation in exon 5 of the DOK7 gene was found in both siblings.

Message

Patients with congenital myasthenic syndrome with DOK 7 mutation benefit remarkably with salbutamol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Engel AG. Current status of the congenital myasthenic syndromes. Neuromuscul Disord. 2012;22:99–111.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Beeson D, Higuchi O, Palace J, Cossins J, Spearman H, Maxwell S, et al. Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 2006;313:1975–8.

    Article  CAS  PubMed  Google Scholar 

  3. Abicht A, Müller JS, Lochmüller H. Congenital Myasthenic Syndromes. 2003 May 9 [Updated 2012 Jun 28]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2014. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1168/

    Google Scholar 

  4. Müller JS, Herczegfalvi A, Vilchez JJ, Colomer J, Bachinski LL, Mihaylova V, et al. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain. 2007;130:1497–506.

    Article  PubMed  Google Scholar 

  5. Palace J, Lashley D, Newsom-Davis J, Cossins J, Maxwell S, Kennett R, et al. Clinical features of the DOK7 neuromuscular Junction synaptopathy. Brain. 2007;130:1507–15.

    Article  PubMed  Google Scholar 

  6. Mahjneh I, Lochmüller H, Muntoni F, Abicht A. DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy. Neuromuscul Disord. 2013;23:36–42.

    Article  PubMed  Google Scholar 

  7. Selcen D, Milone M, Shen XM, Harper CM, Stans AA, Wieben ED, et al. Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients. Ann Neurol 2008; 64:71–87.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Hamuro J, Higuchi O, Okada K, Ueno M, Iemura S, Natsume T, et al. Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7. J Biol Chem. 2008;283:5518–24.

    Article  CAS  PubMed  Google Scholar 

  9. Yamanashi Y, Higuchi O, Beeson D. Dok7/MuSK signaling and a congenital myasthenic syndrome. Acta Myologica. 2008;27:25–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  10. Witting N, Vissing J. Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome. JAMA Neurol. 2014;71:350–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satish Khadilkar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khadilkar, S., Bhutada, A., Nallamilli, B. et al. Limb girdle weakness responding to salbutamol: An Indian family with DOK7 mutation. Indian Pediatr 52, 243–244 (2015). https://doi.org/10.1007/s13312-015-0616-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-015-0616-z

Keywords

Navigation